Lantheus general counsel to retire
Michael Duffy, general counsel and senior vice president for law and public policy will retire from Lantheus Holdings on June 4 after more than 13 years with the North Billerica, Massachusetts-based company.
Duffy’s responsibilities will be assumed by Daniel Niedzwiecki, who has worked at the company since 2013 and will report directly to president and CEO Mary Anne Heino. The company will retain Duffy in an advisory capacity.
According to his LinkedIn profile, Duffy spent six years as senior vice president, general counsel and secretary at Point Therapeutics before joining Lantheus. Before that he was senior vice president, general counsel and secretary of Digital Broadband Communications, having previously held the same title at ETC. Earlier, he worked at Ropes & Gray.
‘On behalf of the entire Lantheus team and board of directors, I thank Mike for his many years of dedicated service to Lantheus and the radiopharmaceutical industry,’ Heino says in a statement. ‘Mike is the consummate professional, a trusted adviser, a good friend and it has been my absolute privilege to have worked with him. We wish Mike all the very best as he embarks on new adventures in his retirement.’
‘I am honored and privileged to have been part of the team that, starting in 2008, transformed a private equity-backed carve-out from Bristol Myers Squibb into a free-standing public company with a growing product portfolio and pipeline, and a market cap that has expanded by more than seven times since the company’s IPO in 2015,’ Duffy says in announcing his retirement.
Lantheus Holdings is the parent company of Lantheus Medical Imaging, Progenics Pharmaceuticals and EXINI Diagnostics, producing imaging diagnostics, targeted therapeutics and artificial intelligence responses to serious medical conditions.